Announces that French genome scientist Daniel Cohen is entering private industry. Resignation as director of the Centre d'Etudes du Polymorphisme Humain (CEPH) in Paris, France; Cohen to merge his research group with the French biotechnology company Genset to create a world-class genome company; Research carried out by Genset including gene regulation and gene sequencing.